Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,943.45 -2,144.55 (-3.40%) CMC Crypto 200
1,259.14 -98.87 (-7.28%)
ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 65.88 |
| Open | 70.00 |
| Bid | 67.81 x 200 |
| Ask | 68.18 x 100 |
| Day's range | 64.05 - 70.00 |
| 52-week range | 38.91 - 70.81 |
| Volume | |
| Avg. volume | 151,787 |
| Market cap | 1.428B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 80.06 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations
Highlights Include Record Net Revenues and Robust Growth in Rare Disease Segment
- Zacks
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
- Zacks
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
© 2024 Yahoo. All rights reserved.